Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Technology Scientific & Technical Instruments
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Charles River Laboratories to Present at UBS and Jefferies Conferences

Business Wire November 11, 2024

Charles River Laboratories Announces Third-Quarter 2024 Results

Business Wire November 6, 2024

Charles River Launches New Retrogenix® Non-Human Protein Library

Business Wire October 17, 2024

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

Business Wire October 16, 2024

Charles River Provides Translational Expertise at Neuroscience 2024

Business Wire October 3, 2024

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

Business Wire October 2, 2024

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

Business Wire September 17, 2024

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Business Wire September 4, 2024

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Business Wire September 3, 2024

Charles River Laboratories Announces Second-Quarter 2024 Results

Business Wire August 7, 2024

Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development

Business Wire July 30, 2024

Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery

Business Wire July 24, 2024

Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call

Business Wire July 16, 2024

Charles River to Perform Plasmid Manufacturing for AAVantgarde

Business Wire July 8, 2024

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

Business Wire June 25, 2024

CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary Duties

Accesswire June 17, 2024

Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy

Business Wire June 17, 2024

Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives

Business Wire June 11, 2024

Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville

Business Wire June 6, 2024

Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research

Business Wire June 4, 2024